Richard Francis
Algemeen Directeur bij
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Vermogen: 41 M $ op 31-05-2026
Profiel
Richard Francis is President, Chief Executive Officer & Director at Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc. since 2023.
Mr. Francis is Director at Mettler-Toledo (Schweiz) GmbH since 2016 and Director at Purespring Therapeutics Ltd. since 2021.
Former roles include Chief Executive Officer & Division Head at Sandoz International GmbH from 2014 to 2019, Chief Executive Officer at Forcefield Therapeutics Ltd., Independent Director at Mettler-Toledo International, Inc. from 2016 to 2025, and Senior Vice President at Biogen, Inc. from 2006 to 2014.
Education includes an undergraduate degree from Manchester Metropolitan University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 05-06-2026 | 1.177.529 ( 0,1% ) | 41 M $ | 31-05-2026 |
Laatste nieuws over Richard Francis
Actieve functies van Richard Francis
| Bedrijven | Functie | Begin |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Algemeen Directeur | 01-01-2023 |
Purespring Therapeutics Ltd.
 Purespring Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for the treatment of kidney diseases | Directeur/Bestuurslid | 01-01-2023 |
Mettler-Toledo (Schweiz) GmbH
 Mettler-Toledo (Schweiz) GmbH Industrial MachineryProducer Manufacturing Makes weighing equipment | Directeur/Bestuurslid | 01-05-2016 |
Teva Pharmaceuticals USA, Inc.
 Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Manufacture and marketing generic pharmaceuticals | Algemeen Directeur | 01-01-2023 |
Eerdere bekende functies van Richard Francis
| Bedrijven | Functie | Einde |
|---|---|---|
| METTLER-TOLEDO INTERNATIONAL, INC. | Directeur/Bestuurslid | 01-05-2025 |
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals | Algemeen Directeur | 31-03-2019 |
| BIOGEN INC. | Corporate Officer/Principal | 01-01-2014 |
Forcefield Therapeutics Ltd.
 Forcefield Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics to retain heart function via protection of cardiomyocytes | Algemeen Directeur | - |
Opleiding van Richard Francis
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
69
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Mettler-Toledo International, Inc.
 Mettler-Toledo International, Inc. Medical SpecialtiesHealth Technology Manufactures and supplies precision instruments | Health Technology |
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals | Health Technology |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Manufacture and marketing generic pharmaceuticals | Health Technology |
Manchester Metropolitan University
 Manchester Metropolitan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mettler-Toledo (Schweiz) GmbH
Mettler-Toledo (Schweiz) GmbH Industrial MachineryProducer Manufacturing Makes weighing equipment | Producer Manufacturing |
Purespring Therapeutics Ltd.
Purespring Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for the treatment of kidney diseases | Health Technology |
Forcefield Therapeutics Ltd.
Forcefield Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics to retain heart function via protection of cardiomyocytes | Health Technology |
